IL-33 is an epithelial-derived “alarmin” playing multiple functions in Th2-related immunopathologies and recently implied in cancer immunity, exerting pro- or anti-tumoral activities, depending on the tumor type and microenvironmental factors [15]. Here, IL33 is linked to cancer.